ISBT 2017

 

From June 17th till June 21st the 27th Regional Congress of ISBT (International Society of Blood Transfusion) will take place in Copenhagen, Denmark.  The ISBT congress offers the opportunity for medical professionals to get together and share expertise in blood safety.

At the congress, Cerus will present a satellite symposium entitled: ‘INTERCEPTTM Blood System after > 2 million platelet transfusions: Clinical evidence and contribution of multi-dose workflows on affordability’. The symposium will take place on Monday June 19th, from 12:00 to 13:30 and will exclusively focus on the pathogen inactivation of platelets.

Here are details on the speakers and their focus areas:

Introduction

R. Henschler, Blutspendedienst SRK, Zurich, Switzerland

Implementation of double dose pathogen inactivated platelets in routine with productivity and cost optimization

MB S. Madsen, Klinisk Immunologi - Aalborg University Hospital, Aalborg, Denmark

Current clinical results with INTERCEPT platelet concentrates

R. Henschler, Blutspendedienst SRK, Zurich, Switzerland

Validation of INTERCEPT triple storage processing sets with high yield buffy coat and apheresis platelets

T. Najdovski, Service du Sang de la Croix-Rouge de Belgique, Suarlée, Belgium  

 

INTERCEPT, the world’s leading pathogen inactivation technology, will also be discussed in three oral presentations that will be delivered at ISBT Copenhagen:

Monday 8:45 – 9:00 -> room C15

Cryopreservation of Buffy Coat Platelet Concentrates Photochemically Treated with Amotosalen and UVA Light

P. Sandgren, Deparment of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

    

            Monday 16:30 – 16:45 -> room C10

Effect of pathogen inactivation on the quality and miRNA profile of platelet cocentrates during storage under standard blood banking condition

N. Árni Árnason, R. Landrö, B. Harðarson,  S. Guðmundsson, Ó. E. Sigurjónsson – The Blood Bank, Landspitali-The National University Hospital of Iceland

 

            Tuesday 17:00 – 17:15 -> room C12

Pathogen Inactivation of Zika, Dengue and Chikungunya Viruses in All Blood Components

D. Musso, M Aubry – Unit of Emerging Infectious Diseases, Institut Louis Malarde, Papeete, French Polynesia

 

In addition, pathogen inactivation and INTERCEPT will be included in 14 poster presentations at the congress, click here to view the list.

Be sure to also visit our Cerus representatives at our booth C3.403.

 

Visit the ISBT website